PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 219 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.77 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $7,537,403 | +108853.5% | 184,695 | +3.1% | 0.22% | +0.5% |
Q4 2022 | $6,918 | -99.9% | 179,174 | +19.1% | 0.22% | -16.2% |
Q3 2022 | $8,003,000 | +4.7% | 150,462 | +14.8% | 0.26% | +12.6% |
Q2 2022 | $7,644,000 | -23.7% | 131,120 | -0.1% | 0.23% | -3.0% |
Q1 2022 | $10,015,000 | -4.9% | 131,229 | -25.0% | 0.24% | +12.3% |
Q4 2021 | $10,530,000 | +21.4% | 175,011 | +13.0% | 0.21% | +17.2% |
Q3 2021 | $8,677,000 | -22.9% | 154,940 | -16.4% | 0.18% | -10.9% |
Q2 2021 | $11,249,000 | -17.1% | 185,375 | -4.3% | 0.20% | -19.8% |
Q1 2021 | $13,571,000 | +2.7% | 193,625 | -12.3% | 0.25% | +0.4% |
Q4 2020 | $13,208,000 | -8.7% | 220,722 | -8.3% | 0.25% | -34.6% |
Q3 2020 | $14,471,000 | -5.8% | 240,696 | -17.8% | 0.38% | -12.1% |
Q2 2020 | $15,368,000 | +36.6% | 292,898 | -12.7% | 0.44% | +8.4% |
Q1 2020 | $11,250,000 | -25.9% | 335,519 | +0.1% | 0.40% | +4.1% |
Q4 2019 | $15,178,000 | +17.6% | 335,062 | -1.2% | 0.39% | +10.3% |
Q3 2019 | $12,904,000 | -0.7% | 338,964 | +13.5% | 0.35% | +9.3% |
Q2 2019 | $12,993,000 | +41.0% | 298,761 | +23.4% | 0.32% | +39.6% |
Q1 2019 | $9,212,000 | +6.5% | 242,028 | +20.3% | 0.23% | -5.7% |
Q4 2018 | $8,653,000 | -21.7% | 201,139 | -10.5% | 0.24% | -6.9% |
Q3 2018 | $11,046,000 | +27.4% | 224,747 | -16.9% | 0.26% | +20.7% |
Q2 2018 | $8,672,000 | -14.6% | 270,573 | -17.0% | 0.22% | -12.5% |
Q1 2018 | $10,157,000 | -39.3% | 326,056 | -11.1% | 0.25% | -37.1% |
Q4 2017 | $16,735,000 | +10.3% | 366,603 | -9.3% | 0.39% | +8.2% |
Q3 2017 | $15,175,000 | -10.5% | 404,141 | +13.8% | 0.36% | -13.7% |
Q2 2017 | $16,947,000 | -0.1% | 355,282 | -0.3% | 0.42% | -2.1% |
Q1 2017 | $16,960,000 | +42.6% | 356,296 | -3.2% | 0.43% | +39.5% |
Q4 2016 | $11,892,000 | -4.0% | 368,169 | +1.7% | 0.31% | -4.3% |
Q3 2016 | $12,385,000 | – | 361,930 | – | 0.32% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Doma Perpetual Capital Management LLC | 1,000,761 | $28,631,772 | 13.28% |
GAGNON SECURITIES LLC | 596,591 | $17,068,469 | 3.84% |
Sio Capital Management, LLC | 455,500 | $13,031,855 | 3.53% |
Gagnon Advisors, LLC | 133,390 | $3,816,288 | 2.91% |
AlphaCentric Advisors LLC | 117,500 | $3,361,675 | 2.48% |
ARDSLEY ADVISORY PARTNERS LP | 580,000 | $16,593,800 | 2.44% |
RICE HALL JAMES & ASSOCIATES, LLC | 998,625 | $28,570,661 | 1.71% |
Lisanti Capital Growth, LLC | 138,830 | $3,971,926 | 0.96% |
Bridge City Capital, LLC | 84,856 | $2,427,730 | 0.82% |
Rock Springs Capital Management LP | 785,000 | $22,458,850 | 0.68% |